论文部分内容阅读
目的:探讨丹参注射液对糖尿病微血管病变患者糖化血红蛋白、血细胞参数的影响。方法:选取86例糖尿病微血管病变患者作为研究对象,其中对照组采取常规治疗,观察组在此基础上,采取丹参注射液治疗;对比两组治疗前后的糖化血红蛋白(GHbA1c)、血细胞参数。结果:治疗后,观察组患者的GHbA1c、MCV、RDW、WBC、MPV、PDW水平均显著下降,且与对照组对比,具有显著性差异(P<0.05)。结论:丹参注射液对糖尿病微血管病变患者的疗效确切,可改善血糖代谢水平及血流动力学,对于缓解微血管病变具有积极作用,临床应用前景广阔。
Objective: To investigate the effect of Salvia miltiorrhiza injection on glycosylated hemoglobin and blood cell parameters in patients with diabetic microangiopathy. Methods: Eighty-six patients with diabetic microangiopathy were selected as study subjects. The control group was given routine treatment. The observation group was treated with Salvia Miltiorrhiza injection. The GHbA1c and blood cell parameters were compared between the two groups before and after treatment. Results: After treatment, the levels of GHbA1c, MCV, RDW, WBC, MPV and PDW in the observation group decreased significantly compared with the control group (P <0.05). Conclusion: Salvia miltiorrhiza injection is effective in treating patients with diabetic microangiopathy, improving blood glucose metabolism and hemodynamics, and has a positive effect on relieving microangiopathy. The clinical application is promising.